ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

NCAB Committee Still Debating How To Encourage Surgical Oncology

April 26, 1985

FDA, Clinical Investigators Head Or Showdown Over Demand To See Individual Patient Records

April 18, 1980

Satraplatin Improved PFS In Refractory Prostate Cancer

July 25, 2003

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

November 1, 2012

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

March 29, 2013

Generic Drug Makers Set Sights In Taxol Worldwide Market

April 2, 1993